RedChip Companies
|
|
Weekly Newsletter
|
|
BioVie Presents Data Showing How NE3107 May Potentially Regulate DNA Methylation of Specific Genes in a Manner Highly Correlated to Observed Improvements in Cognition and Biomarkers of Disease
|
BioVie (Nasdaq: BIVI), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, announced data from a poster detailing the epigenetic basis for how in a Phase 2 exploratory biomarker study its drug candidate NE3107 may have potentially regulated specific genes in a manner significantly correlated with observed cognitive and biomarker improvements. The poster was presented on July 16 at the Alzheimer’s Associate’s International Conference (AAIC) held in Amsterdam.
For more information, visit www.bioviepharma.com
|
Aridis Receives Agreement from the European Medicines Agency (EMA) on the Clinical Study Design and a Single Confirmatory Phase 3 Study of AR-301
Aridis Pharmaceuticals (OTC: ARDS) announced positive feedback from the European Medicines Agency (EMA) on the Company’s proposed single confirmatory Phase 3 study of investigational monoclonal antibody candidate AR-301, which is being developed as an adjunctive therapy in combination with standard of care (SOC) antibiotics for the treatment of pneumonia caused by Gram-positive bacteria Staphylococcus aureus (S. aureus) in mechanically ventilated hospitalized patients.
|
Unicycive Therapeutics Announces Publication of Positive Comparison of Oxylanthanum Carbonate to Commercially Available Phosphate Binders in the American Journal of Nephrology
Unicycive Therapeutics (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, announced that the peer-reviewed international journal the American Journal of Nephrology has published positive results on the phosphate binding capacity for oxylanthanum carbonate (OLC).
|
|
|
American Resources Corporation’s ReElement Technologies Appoints Automotive and EV Industry Veteran Alex Hitzinger to Its Technical Advisory Board
American Resources’ (Nasdaq: AREC) subsidiary ReElement Technologies LLC, a leading provider of high performance refining capacity of battery and rare earth elements, today announced the appointment of automotive and EV industry veteran Alex Hitzinger to its Technical Advisory Board.
|
Everything Blockchain, Inc. Named a Finalist for CRN’s 2023 Tech Innovator Award
Everything Blockchain (OTC: EBZT), a technology company that is blending blockchain, DBMS and Zero Trust to deliver disruptive new ways to store, manage and protect data, today announced that CRN®, a brand of The Channel Company, has named EBI as a Finalist for the 2023 CRN Tech Innovator Awards. EBI is being recognized for BuildDB in the Data and Information Management category.
|
|
|
Small Stocks Big Money™ Podcasts
|
|
|
Upcoming Events |
|
|
|
|
| NYSE American: GRFX - Graphex Group |
| 4:15pm Eastern |
| Graphex Group is a global leader in the mid-stream deep processing of natural spherical graphite and graphene-related products, key components of the Lithium-ion (Li-ion) batteries used in Electric Vehicles (EVs), renewable energy storage systems, and other use cases. |
|
|
|
|
|
| NASDAQ: STSS - Sharps Technology |
| 4:15pm Eastern |
| Sharps Technology is a medical device and pharmaceutical packaging company specializing in the development and manufacturing of innovative drug delivery systems. |
|
|
|
|
|
| NASDAQ: ARDS - Aridis Pharmaceuticals |
| 4:15pm Eastern |
| Aridis Pharmaceuticals, Inc. discovers and develops novel anti-infective therapies to treat life-threatening infections, including anti-infectives to be used as add-on treatments to standard-of-care antibiotics. |
|
|
|
|
|
| NASDAQ: GENE - Genetic Technologies Limited |
| 4:15pm Eastern |
| Genetic Technologies Limited is a diversified molecular diagnostics company developing tools for the prediction and assessment of chronic disease risk to help physicians proactively manage patient health. |
|
|
|
|
|
| NYSE American: ZOM - Zomedica |
| 4:15pm Eastern |
| Zomedica is revolutionizing veterinary health care with a focus on addressing unmet needs through its expanding product portfolio of innovative diagnostics and medical devices designed to improve pet health as well as productivity and practice profitability for veterinarians. |
|
|
|
|
|
| NASDAQ: DGLY - Digital Ally |
| 4:15pm Eastern |
| Digital Ally Companies is a diversified holding company with operations in video solution technology, human and animal health protection products, healthcare revenue cycle management, ticket brokering and marketing, and event production. |
|
|
|
|
|
| OTCQB: AMNI - American Noble Gas |
| 4:15pm Eastern |
| American Noble Gas Inc is active in the energy sector. It has conducted an environmental study and developed geological information from the reprocessing and additional evaluation of existing two-dimensional (2-D) seismic data in the Perlas and Tyra concession blocks. |
|
|
|
|
|
| NASDAQ: SXTP - Sixty Degrees Pharmaceuticals |
| 4:15pm Eastern |
| 60 Degrees Pharmaceuticals (60P) is a growth-oriented biotechnology company with a goal of using cutting-edge biological science and applied research to further develop and commercialize new therapies for the prevention and treatment of infectious diseases. |
|
|
|
|
|
| NASDAQ: ASPI - ASP Isotopes |
| 4:15pm Eastern |
| ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. |
|
|
Archive Events |
|
|
|
|
| NASDAQ: SNGX - Soligenix |
| Meeting Duration 48 minutes |
| Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. |
|
|
|
|
|
| OTCQB: QYOUF - QYOU Media |
| Meeting Duration 46 minutes |
| QYOU Media operates in India and the United States producing and distributing content created by social media stars and digital content creators. |
|
|
|
|
|
| NASDAQ: BIVI - BioVie |
| Meeting Duration 47 minutes |
| BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease. |
|
|
|
|
|
| NASDAQ: SPI - SPI Energy |
| Meeting Duration 33 minutes |
| We are delighted to invite you to SPI Energy's Investor Day 2023, where you will have the chance to learn more about our strategic vision and growth plans and hear from key members of our leadership team. |
|
|
|
|
|
| NASDAQ: BFRG - BullFrog AI |
| Meeting Duration 31 minutes |
| BullFrog AI is a digital technology company using machine learning to usher in a new era of precision medicine. Through its collaborations with leading research institutions, including Johns Hopkins University, BullFrog AI is at the forefront of AI-driven drug development. |
|
|
|
|
|
| NASDAQ: ASPI - ASP Isotopes |
| Meeting Duration 39 minutes |
| ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. |
|
|
|
|
|
| NASDAQ: ARDS - Aridis Pharmaceuticals |
| Meeting Duration 48 minutes |
| Aridis Pharmaceuticals, Inc. discovers and develops novel anti-infective therapies to treat life-threatening infections, including anti-infectives to be used as add-on treatments to standard-of-care antibiotics. |
|
|
|
|
|
| NASDAQ: RVSN - Rail Vision |
| Meeting Duration 36 minutes |
| Rail Vision is the leading provider of obstacle detection and classification systems in the railway industry. |
|
|
|
|
|
| NYSE American: GNS - Genius Group |
| Meeting Duration 44 minutes |
| Genius Group is a world leading entrepreneur Edtech and education group, with a mission to disrupt the current education model with a student-centered, life-long learning curriculum that prepares students with the leadership, entrepreneurial and life skills to succeed in today’s market. |
|
|
|
|
|
| NASDAQ: STSS - Sharps Technology |
| Meeting Duration 48 minutes |
| Sharps Technology is a medical device and pharmaceutical packaging company specializing in the development and manufacturing of innovative drug delivery systems. |
|
|
|
|
|
| NASDAQ: LTRN - Lantern Pharma |
| Meeting Duration 34 minutes |
| Lantern Pharma is a clinical stage oncology-focused company who is harnessing the power of Artificial Intelligence and Genomics to develop precision cancer therapies. |
|
|
Lesson of the Week
If you want a significant return on an investment, you've got to be willing to bet against the crowd.
|
|
|
MidSouth Week in Review
Economists expect a July rate increase of 5.25% to 5.50% this month but none in September.
|
|
|
You are receiving this email because your email is subscribed to our mailing list.
Click here to update your subscription or unsubscribe your email address.
Copyright © 2023. All rights reserved.
|
|
© 2023 RedChip , All rights reserved
|
|
| |
|
|
